$BlogRSDUrl$>
Cloud, Digital, SaaS, Enterprise 2.0, Enterprise Software, CIO, Social Media, Mobility, Trends, Markets, Thoughts, Technologies, Outsourcing
Contact
Contact Me:
sadagopan@gmail.com
Linkedin
Facebook
Twitter
Google Profile
Search
www
This Blog
Resources
Mckinseyquarterly
Strategy + Business
Sandhill Group
CIOInsight
Seth Godin
Om Malik
Enterprise Irregulars
Lens360
Cloud Ave
Enterprise Irregulars
Tom Foremski
Labels
Enter your email address below to subscribe to this
Blog
!
powered by Bloglet
online
Archives
January 2004
February 2004
March 2004
April 2004
May 2004
June 2004
July 2004
August 2004
September 2004
October 2004
November 2004
December 2004
January 2005
February 2005
March 2005
April 2005
May 2005
June 2005
July 2005
August 2005
September 2005
October 2005
November 2005
December 2005
January 2006
February 2006
March 2006
April 2006
May 2006
June 2006
July 2006
August 2006
September 2006
October 2006
November 2006
December 2006
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
August 2007
September 2007
October 2007
November 2007
December 2007
January 2008
February 2008
March 2008
May 2008
June 2008
July 2008
September 2008
October 2008
November 2008
December 2008
February 2009
March 2009
September 2009
October 2009
November 2009
December 2009
February 2010
March 2010
April 2010
May 2010
June 2010
July 2010
August 2010
September 2010
October 2010
November 2010
December 2010
March 2011
April 2011
May 2011
October 2011
January 2012
September 2012
November 2012
February 2014
September 2014
October 2014
March 2015
April 2015
June 2015
March 2016
September 2017
September 2020
July 2021
August 2023
October 2023
November 2023
December 2023
February 2024
March 2024
May 2024
August 2024
Tuesday, June 15, 2004
An open-source shot in the arm , for medical research via Economist
Medicine: The open-source model is a good way to produce software, as the example of Linux shows. Could the same collaborative approach now revitalise medical research too?CAN goodwill, aggregated over the internet, produce good medicine? The current approach to drug discovery works up to a point, but it is far from perfect. It is costly to develop medicines and get regulatory approval. The patent system can foreclose new uses or enhancements by outside researchers. And there has to be a consumer willing (or able) to pay for the resulting drugs, in order to justify the cost of drug development. Pharmaceutical companies have little incentive to develop treatments for diseases that particularly afflict the poor, for example, since the people who need such treatments most may not be able to afford them.
Open source is a decentralised form of production in which the underlying programming instructions, or “source code”, for a given piece of software are made freely available. Anyone can look at it, modify it, or improve it, provided they agree to share their modifications under the same terms
.This interesting article explores whether or not the open-source software movement can be applied to pharmaceutical drug development. This highlights a couple of areas where such collaboration might be effective--drugs whose patents have expired (other uses for aspirin, for instance) and diseases that affect small numbers of people or are mostly found in poor countries.
There are a number of other similarities between biomedical research and open-source software development. First, both fields attract the same sort of people. Biology, like software, relies on teams of volunteers, notably graduate students and young professionals, who have an incentive to get involved because it will enhance their professional reputations or establish expertise. Both medical biologists and computer scientists aim to improve people's lives and make the world a better place. And as the human-genome project showed, both cultures respond strongly to grand projects, not just financial incentives—possibly because they are generally highly paid to begin with. Dissimilarities also abound
|
ThinkExist.com Quotes
Sadagopan's Weblog on Emerging Technologies, Trends,Thoughts, Ideas & Cyberworld
"All views expressed are my personal views are not related in any way to my employer"